Chemical Works of Gedeon Richter Plc
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
RICHT | BUD
Overview
Corporate Details
- ISIN(s):
- HU0000067624 (+3 more)
- LEI:
- 549300J6ZJW5IH4WEE46
- Country:
- Hungary
- Address:
- GYOMROI UT 19-21, 1103 BUDAPEST
- Sector:
- Manufacturing
Description
Chemical Works of Gedeon Richter Plc. is a multinational, vertically integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of medicinal products. The company's core therapeutic areas include women's health, central nervous system disorders, and cardiovascular diseases, with additional activity in oncology. Its portfolio consists of original research drugs, active pharmaceutical ingredients (APIs), and generic medicines. Founded in 1901, Gedeon Richter focuses on delivering high-value therapies to improve the quality of life for patients globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-09 10:32 |
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
|
Hungarian | 1.4 MB | ||
| 2025-10-09 10:32 |
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
|
English | 1.4 MB | ||
| 2025-09-30 14:34 |
Voting rights, registered capital
|
Hungarian | 243.0 KB | ||
| 2025-09-30 14:34 |
Voting rights, registered capital
|
English | 206.1 KB | ||
| 2025-09-29 08:00 |
Richter and Hikma receive FDA approval for denosumab biosimilars EnobyTM and Xt…
|
Hungarian | 420.4 KB | ||
| 2025-09-29 08:00 |
Richter and Hikma receive FDA approval for denosumab biosimilars EnobyTM and Xt…
|
English | 357.7 KB | ||
| 2025-09-01 10:29 |
Voting rights, registered capital
|
Hungarian | 243.4 KB | ||
| 2025-09-01 10:29 |
Voting rights, registered capital
|
English | 207.0 KB | ||
| 2025-08-27 17:35 |
The European Commission approves Bio-Thera’s BAT2206 (USYMRO®, a biosimilar ust…
|
Hungarian | 334.5 KB | ||
| 2025-08-27 17:35 |
The European Commission approves Bio-Thera’s BAT2206 (USYMRO®, a biosimilar ust…
|
English | 322.0 KB | ||
| 2025-08-06 05:55 |
2025 Half-yearly Report
|
English | 1.1 MB | ||
| 2025-08-06 05:55 |
2025 Half-yearly Report
|
Hungarian | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all Chemical Works of Gedeon Richter Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chemical Works of Gedeon Richter Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chemical Works of Gedeon Richter Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
